Abstract Objective To characterize cumulative physiologic dysfunction (CPD) in pregnancy as a measure of the biological effects of chronic stress and to examine its associations with gestational age and birth weight. Methods Women B28 weeks gestation were enrolled from obstetric clinics in Rochester, NY and followed through their delivery. CPD parameters included total cholesterol, Interleukin 6 (IL-6), high sensitivity-C-reactive protein (hs-CRP), systolic and diastolic blood pressure, body mass index at \14 weeks gestation, glucose tolerance, and urinary albumin collected in the third trimester. Linear regression was used to estimate the association between physiologic dysfunction and birth weight and gestational age, respectively (N = 111). Results CPD scores ranged from 0 to 6, out of a total of 8 parameters (Mean 2.09; SD = 1.42). Three-fourths of the participants had a CPD score of 3.0 or lower. The mean birth weight was 3397 g (SD = 522.89), and the mean gestational age was 39.64 weeks (SD = 1.08). CPD was not significantly associated with either birth weight or gestational age (p = 0.42 and p = 0.44, respectively). Conclusion CPD measured at[28 weeks was not associated with birth weight or gestational age. Refinement of a CPD score for pregnancy is needed, taking into consideration both the component parameters and clinical and pre-clinical cut-points for risk scoring.
Significance
What is known? The association between psychosocial stress and adverse birth outcomes is well established but poorly understood. Allostatic load, a conceptual framework for physiological dysfunction arising from exposure to chronic stress, refers to the cumulative, physiological toll imposed on the body from the ongoing activation of the stress response.
What does this study add? Cumulative physiologic dysfunction has been theoretically applied to pregnant populations to explain adverse birth outcomes; our study was one of the first to characterize it during pregnancy. We found no evidence that physiologic dysfunction measured in pregnancy, as operationalized in this study, was associated with adverse birth outcomes.
Background
Understanding the etiologies of preterm birth (PTB) and low birth weight are among the most pressing public health issues (Institute of Medicine Committee on Understanding Premature Birth and Assuring Healthy Outcomes 2007), not only for their immediate costs to society but also for their latent effects on offspring risk of cardiovascular disease and type 2 diabetes (Barker 1995; Barker et al. 1989 ). Previous studies have demonstrated an inconsistent association between chronic maternal stress and adverse birth outcomes, in part due to heterogeneity in the scales and constructs that have been employed in the literature (Hobel et al. 2008) . Prior research has shown the strongest associations with PTB using perceived stress, pregnancy-related anxiety, and life events scales early in pregnancy (Witt 2014; Hobel et al. 2008; Shapiro 2013) .
Population-based and animal studies suggest maternal stress is associated with adverse birth outcomes through neuroendocrine, inflammatory, and behavioral pathways. Stress has a cascading impact on an individual's appraisal and perception, biology, and subsequent level of adaptation, which incorporates multiple domains of stress (e.g. environmental, psychological, and biological) and time periods in a woman's life (e.g. preconception, the interconception period, and pregnancy) that might affect the health of her offspring although the underlying biological mechanisms remain poorly understood (Muglia and Katz 2010) .
Allostatic load, which is hypothesized to reflect cumulative physiological dysfunction (CPD), is a conceptual framework for describing the toll imposed on the body from the ongoing activation of the stress response that often manifests in sub-clinical variations in neuroendocrine, cardiovascular, metabolic, inflammatory, and renal domains (McEwen 1998) . It is cumulative in the sense of capturing the latent biological effects of chronic stress across multiple physiological systems (i.e. the sum of a range of parameters) and has been theoretically posited to be causally related to both PTB and low birth weight (Gupta et al. 2015; Lu and Halfon 2003; Shannon et al. 2007 ). It may also be one possible mechanism driving health disparities; black women and individuals of lower socio-economic status, both of whom are more likely to have adverse birth outcomes (Martin et al. 2010) , have been shown to have higher physiologic dysfunction burdens (Geronimus et al. 2006) . Although biologically plausible in explaining birth disparities, how CPD may be manifested and measured in pregnancy is largely unknown.
The purpose of this study was to characterize CPD in pregnancy as a measure of the biological effects of chronic stress and to examine its associations with gestational age and birth weight. We hypothesized that higher maternal physiologic dysfunction scores would be associated with shorter gestational lengths and lower infant birth weights.
Methods

Study Population
The study population was drawn from two sources: (1) women enrolled in the e-Moms of Rochester Study, and (2) pregnant patients from one of two obstetric (OB) clinic settings. e-Moms is a randomized clinical trial designed to prevent excessive weight gain and postpartum weight retention using electronically based behavioral interventions in pregnant women from Monroe County, New York (Fernandez et al. 2015) . Pregnant women from the e-Moms study who had agreed to be re-contacted about additional research studies and had not yet delivered by October 2012 were contacted via email and phone and invited to participate in the current study. If interested, a member of the study staff met participants at their next OB visit or home to consent, enroll, and complete data collection. Similarly, between March 2013 and August 2013, women at the OB offices meeting study criteria were presented information about the study from clinic staff, and if interested, were instructed to see study staff, where they were screened, consented, and enrolled. Per participants' preference, follow-up was conducted at a clinic visit or at home.
To be eligible for the study, women had to be 18-35 years of age and \28 weeks gestation at the time of enrollment, plan to deliver in one of the four hospitals in Monroe County, have a singleton pregnancy, and read English. Women who had a body mass index (BMI) [35.0 kg/m 2 , had blood pressure treated with medication at enrollment, and other chronic diseases were excluded; further details on the cohort have been published elsewhere (Fernandez et al. 2015) . Miscarriages and stillbirths (i.e. neonatal death within 24 h of birth) were excluded. The University of Rochester Institutional Review Board approved the study.
Data Collection
Data collection occurred at three time points: (1) prenatal survey at enrollment, (2) at a second visit C28 weeks we collected dried blood spots, and (3) after delivery the birth record and prenatal chart were abstracted for the remaining physiologic dysfunction parameters and outcome variables.
The methods of obtaining, analyzing, and applying dried blood spot (DBS) biomarkers for population research have been published by McDade et al. (2007) . Blood spots were collected by finger prick onto Whatman 903 protein saver cards and dried for 4 h overnight before being packaged with desiccant and stored in a -20°freezer. Sample degradation is minimal at room temperature for at least 2 weeks (McDade et al. 2007 ). Interleukin-6 (IL-6), cholesterol, and high sensitivity C-reactive protein (hs-CRP) content in the DBS were measured using previously published methods (Lakshmi et al. 2012; McDade et al. 2004; Ramakrishnan et al. 2001) . The methods were validated by comparing DBS measurements with venipuncture samples, the gold-standard for validation in a separate cohort (McDade et al. 2004 ). Samples were run in batches using biological duplicates (when the size of the blood spots allowed). Inter-assay coefficients of variation ranged from 6.7 to 12 %, and intra-assay coefficients of variation ranged from 7.1 to 17 % (with the exception of IL-6 because there was not enough sample for biological duplicates) with the following detection limits: IL-6 (0.37 pg/mL), hs-CRP (30 ng/mL), and total cholesterol (43 ng/mL), respectively.
Measures
There were two primary outcomes: birth weight and gestational age. Birth weight, the primary dependent variable, was abstracted from the infant medical chart and treated continuously in grams. Gestational age was measured in weeks using the best estimate of gestational length abstracted from the delivery record; this method of ascertainment in the clinical record integrates information of maternal last menstrual period, ultrasound dating, and clinical exam data. All of the women had a first trimester ultrasound that was used to confirm gestational dating.
The CPD score was constructed from systolic and diastolic blood pressure, early pregnancy BMI (i.e. \14 weeks gestation), urinary albumin, and 1-h glucose tolerance test. These parameters were abstracted from the prenatal medical record at the visit closest to biomarker collection (often the same day). These data were combined with IL-6, high sensitivity CRP, and total cholesterol biomarkers from DBS. All parameters were based on candidate measures from allostatic load domains previously published (Seeman et al. 1997 ). The range of parameter measurement was 28-40 weeks, and the mean was 31.84 weeks. In a separate analysis we adjusted for gestational age at biomarker collection, but it did not qualitatively change the results of the study.
Since this was one of the first studies of CPD in pregnancy, we used CPD parameters used in non-pregnant populations, but we adapted three for pregnancy for pragmatic and scientific reasons. For example, waist-hip ratio is a superior measure for central adiposity in the general population (Gelber et al. 2008 ), but it is not a valid measure of metabolic risk in pregnancy. Similarly, rather than hemoglobin A1C, we used values from the glucose tolerance test, which is the standard of care for screening for insulin sensitivity in pregnancy (i.e. diagnosis of gestational diabetes is based on serial testing of the 1-and 3-h challenge) (Gupta et al. 2015) . The inflammatory markers we chose, IL-6 and hs-CRP, have been used in previous allostatic load studies to capture sub-clinical pro-inflammatory states (Seeman 2010; Singer et al. 2004 ), as well as in studies examining the biological effects of stress during pregnancy and their effect on gestation (Azar 2013; Blackmore 2014; Hebisch et al. 2004) . While cholesterol, blood pressure, and other cardio-metabolic parameters may shift during pregnancy to meet the demands of the growing fetus, recent evidence suggests that maternal metabolic profiles (including early-pregnancy BMI) are associated with offspring adiposity likely due to altered fetal programming (Daraki et al. 2015) . Urinary albumin was selected because it is routinely collected in pregnancy, and while proteinuria may be common in pregnancy, it may also signal infections as well as more serious conditions such as kidney obstructions or pre-eclampsia. Furthermore, although there may be differences in the values of different parameters between pregnant and non-pregnant women, our study only included pregnant women and was designed to detect sub-clinical, relative differences between pregnant women.
In deriving the CPD score, we considered both clinical as well as sub-clinical cut-points previously published in studies among the general population (Singer et al. 2004; Seplaki et al. 2006) . To construct the elevated risk zone score of physiologic dysfunction, individuals were classified according to quartile of each of the discrete physiologic measures, and cut-offs were established at the 75th percentile of the population distribution according to convention in the literature. A point was assigned to each individual's score for each component that exceeded the threshold cut-point.
Covariates included: maternal age at enrollment, marital status, maternal educational attainment, household income, race, and ethnicity based on factors thought to be associated with birth outcomes or CPD. We also included smoking status during pregnancy (i.e. smoking status assessed \28 weeks gestation by self-reported survey). Only covariates that improved the model fit were retained in the adjusted models. Model selection was determined by improvements in the adjusted R-squared as well as inspection of changes in the F-test for the overall model compared to a model with only an intercept.
Statistical Analysis
Descriptive statistics were calculated to characterize physiologic dysfunction in this sample of pregnant women. Bivariate analyses examining the association between CPD and each categorical covariate were first conducted using ANOVA tests to assess the mean differences in CPD across all categories of covariates. Multivariable ordinary least square models were used to estimate the association of physiologic dysfunction with birth weight and gestational age, respectively, while controlling for potential confounders.
A sensitivity analysis was conducted to examine the effect of omitting large for gestational age (LGA) infants and women diagnosed with gestational diabetes (i.e. observations in the far right tail of the birth weight distribution) who were more likely to have macrosomic infants. We utilized multivariable ordinary least square models to estimate the association between CPD and birth weight once these observations were removed.
Results
A total of 181 women were recruited for the study, of whom 168 were retained until delivery. Two of the women delivered prior to 28 weeks gestation, two moved prior to delivery, and there was one stillbirth at 28 weeks. Seven women were lost to follow-up or withdrew their consent. Of the 168 women on whom delivery data were available, N = 111 had complete data for analysis based on availability of the DBS since the amount of sample that was needed was greater than initially planned and collected.
Demographic and other characteristics are shown in Table 1 . A third of the women were Black, and 17 % were Hispanic. Most were in a relationship (42 %) or married (39 %), but only a third had an income of [$50,000 per year. Approximately 13.5 % of the sample reported smoking during their pregnancy, and the majority of the sample had an early pregnancy BMI within the normal range (i.e. 18.5-\25 kg/m 2 ). The birth weight of the sample was approximately normally distributed with a mean of 3397 g (SD = 522.89), of which 3.6 % were low birth weight infants (\2500 g) ( Table 2 ). The distribution of gestational age was also approximately normal with a mean of 39.67 weeks (SD = 1.08). The proportion of PTBs among women retained through delivery was 1.8 %, which was lower than expected (Martin et al. 2010 ) although births \28 weeks gestation were excluded due to the design of the study. Approximately 8.11 % of the infants were small for gestational age (SGA), and 4.5 % were considered LGA based on clinical diagnosis abstracted from the medical chart. The mean gestational age at blood spot collection was 31 weeks.
Among the pregnant women sampled, CPD scores ranged from 0 to 6, out of a total of 8 parameters. The mean was 2.09 (SD = 1.42). The distribution was slightly rightskewed, with 75 % of women having a score of 3 or less. The interquartile range was 2.0.
The 75th percentile for each parameter of the CPD score is listed in Table 3 . Several of the specific components' cut-points using this methodology were similar to established clinical parameters although the cut-points for systolic and diastolic blood pressure were lower in our pregnant sample.
We did not find statistically significant associations between CPD score and birth weight in the unadjusted (p = 0.59) or in the adjusted model (p = 0.42) when accounting for race, income, and smoking status. In the adjusted analysis, there was a reduction in birth weight of 276.77 g for women with household incomes\$20,000 per year (p = 0.04) and a 298.98 g reduction for women with household incomes $20,000-$50,000 per year compared to (Table 4) . A sensitivity analysis was also conducted to examine the effect of omitting LGA infants and women diagnosed with gestational diabetes. When these observations were removed from the dataset, the b-coefficient for CPD was negative as hypothesized although it was not significant (p = 0.68). There was a significant reduction in birth weight of 350.69 g for women with household incomes \$20,000 per year and a 280.08 g reduction for women with household incomes $20,000-$50,000 per year compared to women with household incomes [$50,000 per year (data not shown). Black race was also significantly inversely associated with birth weight in this subset (b = -223.74; p = 0.02).
Although birth weight and gestational age are related, they are distinct outcomes that may differ in their underlying pathophysiology. Therefore, a multivariable model adjusted for gestational age was also estimated. We found that for each week of gestation at birth, there was an increase of 170.34 g in birth weight (p \ .001) although it did not qualitatively change the results.
We also examined gestational age, treated continuously, as an outcome. In the bivariate analysis and the unadjusted model, gestational age was not associated with CPD score (p = 0.56). After adjustment for race, income, education, relationship status, and smoking, CPD remained insignificant, but the coefficient was negative as hypothesized (b = -0.06 weeks; p = 0.44) ( Table 5 ).
Discussion
Our analysis is one of the first studies to examine CPD in pregnancy and the first to incorporate inflammatory biomarkers into a measure of CPD in pregnancy. As such, it required adapting a measure of CPD using methods for characterizing allostatic load in the general population in relation to health outcomes more common in older adults (Seplaki et al. 2004; Logan and Barksdale 2008) for one in pregnancy.
Only a few studies have examined physiologic dysfunction in relation to pregnancy, most of which measured allostatic load prior to or after pregnancy Morrison et al. 2013 ). In one study, CPD parameter components were collected an average of 6.8 years prior to conception (Wallace et al. 2013) with a mean age of 13 years, which likely did not adequately capture the divergence in allostatic load trajectories as women age that Geronimus et al. have reported (Geronimus et al. 2006) . Although blood was collected via venipuncture preconceptionally rather than from DBS in the third trimester of gestation, the upper quartile of allostatic load overall was 3 in both studies, and the means and standard deviations were similar. Our results were also consistent with Morrison et al. in terms of their description and distribution of physiologic dysfunction in pregnancy although they did not examine birth outcomes (Morrison et al. 2013) . Using NHANES data, Hux et al. found that women with a history of SGA or PTBs had higher physiologic dysfunction burdens postpartum than did those with normal birth weight outcomes when adjusted for BMI (Hux et al. 2014 ). Temporality was not established in their study, which given the potential bi-directional association between adverse birth outcomes and physiologic dysfunction, is an important consideration for future research.
In the one other study to date that has attempted to measure allostatic load in pregnancy, blood samples from 42 women at 26-28 weeks gestation were assayed for cholesterol, glycosylated hemoglobin, dehydroepiandrosterone-sulfate, and serum cortisol (not a bioavailable form of cortisol) and were added together with systolic blood pressure . In contrast to our results, black women unexpectedly had a significantly lower allostatic load index than white women, and gestational age at birth was the only outcome significantly associated with allostatic load although the magnitude of the effect was small (adjusted b = -0.18, 95 % CI -0.35, 0.00). The extent to which their results may have been impacted by a lack of inflammatory markers in their measure is unknown.
While there was some variation in the pregnancyspecific components of our measure of CPD from those used previously in the literature (Dowd et al. 2009; Seeman et al. 2001 Seeman et al. , 2010 , our measure expanded upon the few studies of allostatic load in women of reproductive age by including cardiovascular, metabolic, inflammatory, and kidney function parameters. We replaced waist-to-hip ratio by early pregnancy BMI abstracted from the medical chart, and glycosylated hemoglobin was replaced by the 1-h glucose tolerance challenge test (i.e. 50 g of administered glucose) (Gupta et al. 2015 ; Committee on Practice Bulletins-Obstetrics 2013).
In terms of cut-points for the CPD components in our study, the pregnancy risk zones were very similar to those observed in non-pregnant populations (Seeman et al. 2010; Peek et al. 2010) . Following the literature (Singer et al. 2004) , risk zones were dichotomized at [75 % percentile in our study, and these were quite consistent with clinical cut-points for non-pregnant individuals, with the exception of the glucose tolerance test results, in five out of the eight CPD components.
A limitation to our measure of CPD for pregnancy is that it did not contain any of the ''primary neuroendocrine mediators'' components, such as cortisol, used in the literature (McEwen 1998; Seeman et al. 2001) . Valid measurement of cortisol is difficult; due to its diurnal pattern, salivary cortisol (i.e. its active unbound form) must be collected at multiple times throughout the day, beginning with early morning and should be collected on more than 1 day, given its wide variability within individuals (Dowd et al. 2009; Smyth et al. 1997) . It is also not known how cortisol patterns may vary during pregnancy. For this reason, our CPD measure for pregnancy is more a reflection of the construct of physiologic dysfunction than allostatic load per se.
In our sensitivity analysis-in which women with LGA infants and gestational diabetes were removed from the sample (n = 11)-the significance of our results did not change, but the coefficient for CPD became negative in the model for birth weight, as we initially hypothesized. This may suggest that rather than being an issue of power, some of the CPD parameters and the theoretical model underlying their constructs, should continue to be improved as to better reflect processes of dysregulation among pregnant women, which may differ from that in the general population. Higher values from the glucose tolerance test, for example, were associated with an increase in birth weight (data not shown), which was not entirely surprising given the known association between gestational diabetes and macrosomia and may underscore the need to modify the parameters of CPD for pregnancy and to refine the theoretical model for allostatic load in pregnancy.
Other limitations to our study exist. The power of the study was impacted by the small sample size and the fewer than anticipated low birth weight and preterm infants. The enrollment criteria for our study was based on the parent clinical trial, which may have limited the generalizability of our study by excluding severely obese women, women with multiples, and women with certain health conditions which may have lowered the PTB rate in our study. The lower than expected PTB rate in our study could have shifted our results towards the null. Furthermore, we used DBS for collection of the inflammatory biomarkers and cholesterol, and while the IL-6 and CRP results obtained appear consistent with other studies that have examined inflammatory markers in pregnancy that were collected via venipuncture (Hebisch et al. 2004; Coussons-Read et al. 2007) , how our cholesterol values may have compared to those from venipuncture is unknown (Crimmins et al. 2014) .
In this study, biomarker collection occurred any time in the third trimester. However, CPD may change over the course of pregnancy due to normal physiologic changes associated with pregnancy (e.g. blood volume increases up to 50 %), and thus may need to be assessed multiple times in pregnancy and ideally before conception Morrison et al. 2013) . It is also unknown if the source of IL-6 collection could have made a difference given that it can be obtained from amniotic fluid, cervicovaginally, or from peripheral blood. A more nuanced understanding of the stress response specifically in pregnancy may improve the timing of biomarker collection to more accurately reflect the relevant window of exposures and the biological pathways that result in birth disparities.
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